[alphasaur]

Originally Posted by jeffchap

In a couple years, once they've been fully FDA approved (they haven't yet -- google it) and there are no unintended side effects, I'll probably start taking mRNA vaccines. But I don't want to be in this first round of trials. I still remember when thalidomide, celebrex and fen-phen were once considered safe, only to later be pulled from the market.

They've been working on mRNA vaccines for over a decade, but never brought them to market until everyone panicked over Covid. Do some research yourself to see why not.

How many of you jumped at the chance to get the vaccine, yet say you would never take a chance on a first model year of a new car? Now which poses the most direct risk to you?

Luckily, my entire family and I all had Covid and survived (just like 99.97% of everyone else under 85). So according to most medical experts including Fauci, we're likely to have a longer lasting and more extensive immunity than those taking the vaccine anyway. So why risk it?

Sent from my moto g(8) power using Tapatalk

Actually, mRNA vaccination provides a more robust immune response than being infected with covid:

https://www.biorxiv.org/content/10.1...089v2.full.pdf
"mRNA vaccines induce higher Ab levels and greater Ab breadth than natural
exposure to infection
Mean MFI signals for each of the novel coronavirus antigens in the natural exposure
(actOC and Santa Ana Cares) and vaccination (HCW) groups are plotted in Figure 5A.
Natural exposure in seropositive people induces Abs against NP and all of the spike
fragments (RBD, S1, S2 and S1+S2) with highest levels against NP, full-length spike
(S1+S2) and the S2 domain. The S1 and RBD domains` antibody reactivity are lower in
naturally exposed individuals.
Vaccinated individuals have high Ab levels against full-length spike and the S2 domain
of SARS-CoV-2 Spike, and significantly higher levels of Ab against S1 and the RBD
domains. In natural exposure there was no significant cross-reactivity against SARS S1
or RBD domains. However the vaccine induced significant cross-reactive Abs against
the SARS spike. Cross-reactivity against SARS NP and full-length MERS S protein is
evident in both the natural exposure and vaccinated groups. These results show that
the Ab responses against Spike RBD variants are significantly elevated in vaccinated
individuals compared to those naturally exposed. Vaccination induces more robust Ab
response than natural exposure alone, suggesting that those who have recovered from
COVID may well benefit from the vaccination. "


I agree though that you do have a degree of protection/immunity having already been infected.